Transglutaminase 2 (TGM2) overexpression contributes to triple-negative breast cancer metastasis through AFAP1-dependent pathway

被引:0
|
作者
Piacsek, Mitchell [1 ]
Sand, Andrea [1 ]
Rovin, Richard A. [2 ]
Bosenko, Dmitry [1 ]
Konduri, Santhi D. [1 ]
Tjoe, Judy A. [1 ]
Yin, Jun [1 ]
机构
[1] Aurora Res Inst, Milwaukee, WI USA
[2] Aurora Neurosci Innovat Inst, Milwaukee, WI USA
关键词
D O I
10.1158/1538-7445.AM2019-168
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
168
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Expression of transglutaminase-2 (TGM2) in the prognosis of female invasive breast cancer
    Fiona M. Blows
    H. Raza Ali
    Wei Cope
    Paul D. P. Pharoah
    Claire V. S. Pike
    Elena Provenzano
    Peter Coussons
    BJC Reports, 2 (1):
  • [2] The role of AFAP1-AS1 in mitotic catastrophe and metastasis of triple-negative breast cancer cells by activating the PLK1 signaling pathway
    Cen, Shuizhong
    Peng, Xiaojie
    Deng, Jianwen
    Jin, Haiyun
    Deng, Zhinan
    Lin, Xiaohua
    Zhu, Di
    Jin, Ming
    Zhu, Yanwen
    Zhang, Pusheng
    Luo, Yunfeng
    Huang, Hongyan
    ONCOLOGY RESEARCH, 2023, 31 (03) : 375 - 388
  • [3] Isocitrate dehydrogenase 2 regulates the proliferation of triple-negative breast cancer through the ferroptosis pathway
    Zhang, Chengwu
    Zhou, Yuanhong
    Chen, Tao
    Bhushan, Sudhanshu
    Sun, Shengrong
    Zhang, Panshi
    Yang, Yalong
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [4] The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer
    Ai, Lingbao
    Kim, Wan-Ju
    Demircan, Berna
    Dyer, Lisa M.
    Bray, Kevin J.
    Skehan, Ryan R.
    Massoll, Nicole A.
    Brown, Kevin D.
    CARCINOGENESIS, 2008, 29 (03) : 510 - 518
  • [5] AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer
    Zhang, Kaiming
    Liu, Peng
    Tang, Hailin
    Xie, Xiaoming
    Kong, Yanan
    Song, Cailu
    Qiu, Xingsheng
    Xiao, Xiangsheng
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [6] NSDHL promotes triple-negative breast cancer metastasis through the TGFβ signaling pathway and cholesterol biosynthesis
    Mengting Chen
    Yang Zhao
    Xueli Yang
    Yuanyuan Zhao
    Qiqi Liu
    Yang Liu
    Yifeng Hou
    Hefen Sun
    Wei Jin
    Breast Cancer Research and Treatment, 2021, 187 : 349 - 362
  • [7] NSDHL promotes triple-negative breast cancer metastasis through the TGFβ signaling pathway and cholesterol biosynthesis
    Chen, Mengting
    Zhao, Yang
    Yang, Xueli
    Zhao, Yuanyuan
    Liu, Qiqi
    Liu, Yang
    Hou, Yifeng
    Sun, Hefen
    Jin, Wei
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (02) : 349 - 362
  • [8] RARRES2’s impact on lipid metabolism in triple-negative breast cancer: a pathway to brain metastasis
    Quazi T. H. Shubhra
    Military Medical Research, 10
  • [9] RARRES2's impact on lipid metabolism in triple-negative breast cancer: a pathway to brain metastasis
    Shubhra, Quazi T. H.
    MILITARY MEDICAL RESEARCH, 2023, 10 (01)
  • [10] RARRES2's impact on lipid metabolism in triple-negative breast cancer: a pathway to brain metastasis
    Quazi T
    Military Medical Research, 2024, (02) : 311 - 312